Performance Measure Portfolio

The HIV/AIDS Bureau established a revised performance measure portfolio in November 2013. This revised portfolio focuses on critical areas of HIV care and treatment, and aligns with milestones along the HIV care continuum. The revisions include:

  • Identifying core performance measures that are most critical to the care and treatment of people living with HIV
  • Combining performance measures to address people of all ages living with HIV
  • Promoting relevant performance measures used in other federal programs
  • Archiving performance measures that are no longer consistent with U.S. Department of Health and Human Services guidelines or applicable to the general population

The HIV/AIDS Bureau encourages Ryan White HIV/AIDS Program recipients to use the revised performance measures, including the core performance measures. The core performance measures completed the rigorous National Quality Forum infectious disease endorsement process.Exit Disclaimer

Given the emphasis on using performance measures to improve health of people living with HIV, recipients may trend performance measure data over time and analyze the data for disparities in care. Disparity analyses may include review data for difference in performance in gender, race/ethnicity, age, insurance status, HIV risk, and others.

The revised performance measure portfolio is outlined below.

Performance Measures and Frequently Asked Questions



Frequently Asked Questions:

  • General Information
  • Revised Portfolio
  • Children
  • Oral Health
  • ADAP
  • System
  • Adolescent/Adult

General FAQ (PDF – 44 KB)

Revised Measures FAQ (PDF – 194 KB)

Children FAQ (PDF – 66 KB)

Oral Health FAQ (PDF – 38 KB)


System FAQ (PDF – 51 KB)

Adolescent/Adult FAQ (PDF – 175 KB)

  • HIV Viral Suppression
  • Prescription of HIV Antiretroviral Therapy
  • HIV Medical Visit Frequency
  • Gap in HIV Medical Visits
  • PCP Prophylaxis
  • Annual Retention in Care


Core Measures (PDF – 358 KB)

All Ages:

  • HIV Drug Resistance Testing Before Initiation of Therapy
  • Influenza Immunization
  • Lipid Screening
  • Tuberculosis Screening


All Ages Measures (PDF – 234 KB)


  • Cervical Cancer Screening
  • Chlamydia Screening
  • Gonorrhea Screening
  • Hepatitis B Screening
  • Hepatitis B Vaccination
  • Hepatitis C Screening
  • HIV Risk Counseling
  • Oral Exam
  • Pneumococcal Vaccination
  • Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan
  • Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • Substance Abuse Screening
  • Syphilis Screening


Adolescent and Adult Measures (PDF – 369 KB)


  • MMR Vaccination


Children Measures (PDF – 162 KB)

HIV-Exposed Children:

  • Diagnostic Testing to Exclude HIV Infection in Exposed Infants
  • Neonatal Zidovudine Prophylaxis
  • PCP Prophylaxis for HIV-Exposed Infants


HIV Exposed Children Measures (PDF – 220 KB)


Medical Case Management (MCM):

  • Care Plan
  • Gap in HIV Medical Visits
  • HIV Medical Visit Frequency


MCM Measures (PDF – 231 KB)


Oral Health:

  • Dental and Medical History
  • Dental Treatment Plan
  • Oral Health Education
  • Periodontal Screening or Examination
  • Phase I Treatment Plan Completion


Oral Health Measures (PDF – 254 KB)


  • Application Determination
  • Eligibility Recertification
  • Formulary
  • Inappropriate Anti-Retroviral Regimen


ADAP Measures (PDF – 281 KB)


  • Waiting Time for Initial Access to Outpatient/Ambulatory Medical Care
  • HIV Test Results for People Living with HIV
  • HIV Positivity
  • Late HIV Diagnosis
  • Linkage to HIV Medical Care
  • Housing Status


System Measures (PDF – 271 KB) 

Archived Downloads



Archived:  All Archived Measures (PDF – 121 KB)


  • ARV Therapy for Pregnant Women
  • CD4 T-Cell Count
  • Medical Visits
  • PCP Prophylaxis
  • Adherence Assessment and Counseling
  • Tuberculosis Screening
  • Hepatitis/HIV Alcohol Counseling
  • Influenza Vaccination
  • MAC Prophylaxis
  • Mental Health Screening
  • Tobacco Screening
  • Toxoplasma Screening


Archived Adolescent Adult Measures (PDF – 181 KB)


  • Adherence Assessment and Counseling
  • ARV Therapy
  • CD4 Value
  • Developmental Surveillance
  • Health Care Transition Planning for HIV-infected Youth
  • HIV Drug Resistance Testing Before Initiation of Therapy
  • Lipid Screening
  • Medical Visit
  • PCP Prophylaxis for HIV-Infected Children
  • Planning for Disclosure of HIV Status to Child
  • Tuberculosis Screening

Archived Pediatric Measures (PDF – 83 KB)


All Ages:

  • CD4 Count
  • Viral Load Suppression on ART
  • Viral Load Monitoring


Archived All Ages Measures (PDF – 121 KB)

Medical Case Management (MCM):

  • Medical Visits


Archived MCM Measures (PDF – 16 KB)


  • Disease Status at Time of Entry Into Care
  • Quality Management Program


Archived System Measures (PDF – 35 KB)


Date Last Reviewed:  December 2019